Request Deal Involvement

Pardes Biosciences went public via a SPAC merger with FS Development II in a $276m deal.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Goodwin Procter

legal advisors

Goodwin Procter

Consort Partners

pr advisors

Consort Partners

Gilmartin Group

pr advisors

Gilmartin Group

White & Case

legal advisors

White & Case

Jefferies & Company

financial advisors

Jefferies & Company

Leerink Partners

financial advisors

Leerink Partners

HC Wainwright

financial advisors

HC Wainwright

or

Principals

ECOR1 CAPITAL

bidder

ECOR1 CAPITAL

GMF CAPITAL

bidder

GMF CAPITAL

FORESITE CAPITAL MANAGEMENT LLC

bidder

FORESITE CAPITAL MANAGEMENT LLC

GILEAD SCIENCES

bidder

GILEAD SCIENCES

PARDES BIOSCIENCES

target

PARDES BIOSCIENCES

FS DEVELOPMENT CORP II

bidder

FS DEVELOPMENT CORP II

RA CAPITAL MANAGEMENT

bidder

RA CAPITAL MANAGEMENT

T. ROWE PRICE GROUP INC

bidder

T. ROWE PRICE GROUP INC

MONASHEE INVESTMENT MANAGEMENT

bidder

MONASHEE INVESTMENT MANAGEMENT

FRAZIER HEALTHCARE PARTNERS

bidder

FRAZIER HEALTHCARE PARTNERS

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite